BMS-986165 1609392-27-9

• Customization: Available
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Model NO.: 1609392-27-9
• Quality: Refined
• MW: 422.45
• Mol File: 1609392-27-9.Mol
• Transport Package: Bag/Bottle/Drum
• Specification: Assay99+%
• Trademark: JINLAN PHARM
• Origin: China
• Production Capacity: 100kg/Year

Product Description

Packaging & Shipping

 

 

Our Advantages

Hangzhou Jinlan Pharm-Drugs Technology Co. Ltd.(JL Pharm) is an advanced pharmaceutical corporation with  a laboratory of 1200 square meters in Nanjing city, and cooperative GMP production plants in Beljing, Jiangsu, Zhejiang, Jiangxi, Chengdrand Shandong.We can provide both CDMO technology research and development services, and a ful range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to globapharmaceutical companies during which synthetic route research and development, process reearch and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.

 

 

Product Description

Product Name:   BMS-986165

Synonyms:    
Tyk2-IN-4;
TYK2-IN-4;
BMS986165;
BMS-986165;
BMS 986165;
6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl) phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide;
Deucravacitinib;
Deucravacitinib(BMS986165);
Deucravacitinib (TYK2-IN-4;
6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H?)methylpyridazine-3-carboxamide;
DeucravacitinibQ: What is Deucravacitinib Q: What is the CAS Number of Deucravacitinib

CAS:	1609392-27-9
MF:	C20H22N8O3
MW:	422.45
EINECS:
Product Categories:	API;APIS;API
Mol File:	1609392-27-9.mol